Keady J, Charnigo R, Shaykin J, Prantzalos E, Prantzalos E, Xia M
bioRxiv. 2024; .
PMID: 39713469
PMC: 11661085.
DOI: 10.1101/2024.12.06.627259.
Broberg M, Helaakoski V, Kiiskinen T, Paunio T, Jones S, Mars N
Sleep. 2023; 47(2).
PMID: 37982563
PMC: 10851853.
DOI: 10.1093/sleep/zsad279.
Guo X, Wang S, Lin X, Wang Z, Dou Y, Cao Y
Psychiatr Genet. 2023; 33(5):182-190.
PMID: 37706495
PMC: 10502955.
DOI: 10.1097/YPG.0000000000000344.
Punchaichira T, Kukshal P, Bhatia T, Deshpande S, Thelma B
Mol Neurobiol. 2023; 60(12):6826-6839.
PMID: 37493923
DOI: 10.1007/s12035-023-03496-4.
Ireton K, Xing X, Kim K, Weiner J, Jacobi A, Grover A
J Neurosci. 2023; 43(30):5559-5573.
PMID: 37419689
PMC: 10376936.
DOI: 10.1523/JNEUROSCI.1521-22.2023.
α-Adrenergic receptor-PKC-Pyk2-Src signaling boosts L-type Ca channel Ca1.2 activity and long-term potentiation in rodents.
Man K, Bartels P, Henderson P, Kim K, Shi M, Zhang M
Elife. 2023; 12.
PMID: 37338965
PMC: 10325713.
DOI: 10.7554/eLife.79648.
L-type calcium channels and neuropsychiatric diseases: Insights into genetic risk variant-associated genomic regulation and impact on brain development.
Baker M, Lee A, Rajadhyaksha A
Channels (Austin). 2023; 17(1):2176984.
PMID: 36803254
PMC: 9980663.
DOI: 10.1080/19336950.2023.2176984.
A functional neuroimaging association study on the interplay between two schizophrenia genome-wide associated genes (CACNA1C and ZNF804A).
Guardiola-Ripoll M, Almodovar-Paya C, Lubeiro A, Sotero A, Salvador R, Fuentes-Claramonte P
Eur Arch Psychiatry Clin Neurosci. 2022; 272(7):1229-1239.
PMID: 35796825
DOI: 10.1007/s00406-022-01447-z.
Small Molecules as Modulators of Voltage-Gated Calcium Channels in Neurological Disorders: State of the Art and Perspectives.
Lanzetti S, Di Biase V
Molecules. 2022; 27(4).
PMID: 35209100
PMC: 8879281.
DOI: 10.3390/molecules27041312.
Genetic Testing for Antipsychotic Pharmacotherapy: Bench to Bedside.
Shad M
Behav Sci (Basel). 2021; 11(7).
PMID: 34209185
PMC: 8301006.
DOI: 10.3390/bs11070097.
Update on the Molecular Genetics of Timothy Syndrome.
Bauer R, Timothy K, Golden A
Front Pediatr. 2021; 9:668546.
PMID: 34079780
PMC: 8165229.
DOI: 10.3389/fped.2021.668546.
Social Behavior and Ultrasonic Vocalizations in a Genetic Rat Model Haploinsufficient for the Cross-Disorder Risk Gene .
Wohr M, Kisko T, Schwarting R
Brain Sci. 2021; 11(6).
PMID: 34072335
PMC: 8229447.
DOI: 10.3390/brainsci11060724.
Genetic Risk of Autism Spectrum Disorder in a Pakistani Population.
Khalid M, Raza H, Driessen T, Lee P, Tejwani L, Sami A
Genes (Basel). 2020; 11(10).
PMID: 33076578
PMC: 7602870.
DOI: 10.3390/genes11101206.
Pathogenesis and management of Brugada syndrome in schizophrenia: A scoping review.
Rastogi A, Viani-Walsh D, Akbari S, Gall N, Gaughran F, Lally J
Gen Hosp Psychiatry. 2020; 67:83-91.
PMID: 33065406
PMC: 7537626.
DOI: 10.1016/j.genhosppsych.2020.09.003.
The genome-wide supported CACNA1C gene polymorphisms and the risk of schizophrenia: an updated meta-analysis.
Liu Y, Wu X, Xia X, Yao J, Wang B
BMC Med Genet. 2020; 21(1):159.
PMID: 32770953
PMC: 7414708.
DOI: 10.1186/s12881-020-01084-0.
A molecular approach to treating cognition in schizophrenia by calcium channel blockade: An open-label pilot study of the calcium-channel antagonist isradipine.
Burdick K, Perez-Rodriguez M, Birnbaum R, Shanahan M, Larsen E, Harper C
Schizophr Res Cogn. 2020; 21:100180.
PMID: 32455122
PMC: 7235642.
DOI: 10.1016/j.scog.2020.100180.
Neuronal L-Type Calcium Channel Signaling to the Nucleus Requires a Novel CaMKIIα-Shank3 Interaction.
Perfitt T, Wang X, Dickerson M, Stephenson J, Nakagawa T, Jacobson D
J Neurosci. 2020; 40(10):2000-2014.
PMID: 32019829
PMC: 7055140.
DOI: 10.1523/JNEUROSCI.0893-19.2020.
CACNA1C polymorphism and brain cortical structure in bipolar disorder.
Smedler E, Abe C, Palsson E, Ingvar M, Landen M
J Psychiatry Neurosci. 2019; 45(1):182-187.
PMID: 31829002
PMC: 7828982.
DOI: 10.1503/jpn.190029.
Chronic methamphetamine interacts with BDNF Val66Met to remodel psychosis pathways in the mesocorticolimbic proteome.
Greening D, Notaras M, Chen M, Xu R, Smith J, Cheng L
Mol Psychiatry. 2019; 26(8):4431-4447.
PMID: 31822818
DOI: 10.1038/s41380-019-0617-8.
β Adrenergic Receptor Complexes with the L-Type Ca Channel Ca1.2 and AMPA-Type Glutamate Receptors: Paradigms for Pharmacological Targeting of Protein Interactions.
Man K, Navedo M, Horne M, Hell J
Annu Rev Pharmacol Toxicol. 2019; 60:155-174.
PMID: 31561738
PMC: 7029424.
DOI: 10.1146/annurev-pharmtox-010919-023404.
